From 1 September 2026, the prescriber accreditation requirement for hepatitis B medicines under the PBS Section 100 (s100) Highly Specialised Drugs Program will be removed. As a result, all medical and authorised nurse practitioners will be able to prescribe hepatitis B antiviral treatment without additional specialist accreditation. ASHM is currently updating its website, education and resources to reflect this change.

Find out more

Deadline extended! Abstract session on Asia and the Pacific regions for the 2022 Joint Australasian HIV&AIDS + Sexual Health Conferences

Share the link to this page with others to keep them informed

The Joint Australasian HIV&AIDS + Sexual Health Conferences are pleased to announce a dedicated abstract session focused on Asia and the Pacific regions at the 2022 conferences. 

Abstract session theme-  

Future-Proofing HIV Services: the role of community and clinic run health services, and the sustainability of the health workforce, post the COVID-19 crisis 

The program session organisers are encouraging abstracts both from and about Asia and the Pacific regions that broadly fit within this session theme. 

Both Research Driven Abstracts and Practice-Based Abstracts will be accepted. 

Options for both in-person and pre-recorded or online presentations are available to ensure participation from across the region. 

Abstracts can be submitted directly to [email protected]. Where abstracts cannot be prepared by the deadline, a brief expression of interest may also be considered.